Cytosorbents Corporation (CTSO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 39.77M |
| Enterprise Value | 62.63M |
| P/E Ratio | -1.11 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0.54 |
| Price/Book Ratio | -26.8 |
| Enterprise/Revenue | 1.13 |
| Enterprise/EBITDA | -2.98 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.49 |
| Operating Margin | -0.33 |
| Return On Assets | -0.48 |
| Return On Equity | -4.45 |
| Revenue | 37.06M |
| Revenue/Share | 11.85 |
| Gross Profit | 26.49M |
| EBITDA | -4.36M |
| Net Income | -8.2M |
| Diluted EPS | -2.6 |
| Total Cash | 4.41M |
| Total Cash/Share | 1.41 |
| Total Debt | 26.33M |
| Total Debt/Equity | -35.07 |
| Current Ratio | 0.66 |
| Book Value Per Share | -0.24 |
| 52-Week Change | -65.85 |
| 52-Week High | 20.4 |
| 52-Week Low | 6 |
| Moving Average 50 Days | 7.34 |
| Moving Average 200 Days | 11.19 |
| Average Volume | 12,857 |
| Shares Outstanding | 3.14M |
| % Held by Institutions | 25.69 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | September 08, 2026 |